blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2198866

EP2198866 - Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.04.2013
Database last updated on 16.11.2024
Most recent event   Tooltip26.04.2013Application deemed to be withdrawnpublished on 29.05.2013  [2013/22]
Applicant(s)For all designated states
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404 / US
[2012/28]
Former [2010/25]For all designated states
Gilead Palo Alto, Inc.
333 Lakeside Drive
Foster City CA 94404 / US
Inventor(s)01 / Belardinelli, Luiz
205 Manzanita Avenue
Palo Alto, Ca 94306 / US
02 / Antzelevitch, Charles
101 Sylvan Way
New Hartford, NY 13413 / US
03 / Blackburn, Brent
633 Almond Avenue
Los Altos, CA 94022 / US
 [2010/25]
Representative(s)Schnappauf, Georg, et al
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[N/P]
Former [2010/25]Schnappauf, Georg, et al
Dr. Volker Vossius Patent- und Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
Application number, filing date10002699.604.04.2003
[2010/25]
Priority number, dateUS20020370150P04.04.2002         Original published format: US 370150 P
US20020408292P05.09.2002         Original published format: US 408292 P
US20020422589P30.10.2002         Original published format: US 422589 P
[2010/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2198866
Date:23.06.2010
Language:EN
[2010/25]
Search report(s)(Supplementary) European search report - dispatched on:EP19.05.2010
ClassificationIPC:A61K31/495, A61P9/06
[2010/25]
CPC:
A61K31/495 (EP,KR,US); A61K31/496 (KR); A61P9/00 (EP);
A61P9/06 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2010/25]
Extension statesAL22.12.2010
LT22.12.2010
LV22.12.2010
MK22.12.2010
TitleGerman:Verwendung von Ranolazin zur Herstellung eines Medikaments zur Behandlung von Arrhythmien[2010/25]
English:Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias[2010/25]
French:Utilisation de ranolazine pour la préparation d'un médicament pour le traitement d'arythmies[2010/25]
Examination procedure22.12.2010Amendment by applicant (claims and/or description)
22.12.2010Examination requested  [2011/06]
29.04.2011Despatch of a communication from the examining division (Time limit: M04)
26.08.2011Reply to a communication from the examining division
11.07.2012Despatch of a communication from the examining division (Time limit: M04)
22.11.2012Application deemed to be withdrawn, date of legal effect  [2013/22]
08.01.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/22]
Parent application(s)   TooltipEP03723907.6  / EP1490066
EP08004276.5  / EP1930007
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030723907) is  28.12.2005
Fees paidRenewal fee
15.03.2010Renewal fee patent year 03
15.03.2010Renewal fee patent year 04
15.03.2010Renewal fee patent year 05
15.03.2010Renewal fee patent year 06
15.03.2010Renewal fee patent year 07
15.03.2010Renewal fee patent year 08
25.04.2011Renewal fee patent year 09
28.03.2012Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:SearchJPH03141258  [ ];
 [XD]US4567264  (KLUGE ARTHUR F [US], et al) [XD] 1,3,4,8-10,18-20 * abstract * * examples 12,17 * * Compound of formula I *;
 [A]WO0160348  (CV THERAPEUTICS INC [US], et al) [A] 1-20 * claims 1-17 *;
 [A]US6303607  (WOLFF ANDREW A [US], et al) [A] 1-20 * examples 7,8 *;
 [X]  - GRALINSKI MR, LIGUO CHI ET AL., "Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart", J CARDIOVASC PHARMACOL THERAPEUT, (1996), vol. 1, no. 2, pages 141 - 148, XP009014600 [X] 1,3,4,9,10,20 * abstract * * figure 3 * * page 147 *
 [A]  - VISKIN S S, "Long QT syndromes and torsade de pointes", LANCET, XX, XX, (19991106), vol. 354, no. 9190, ISSN 0140-6736, pages 1625 - 1633, XP004262825 [A] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0140-6736(99)02107-8
 [A]  - SHIBUYA M, TAKAHASHI Y, "Preparation of piperazine derivatives as antiarrhythmics", HCAPLUS, (19910617), Database accession no. 1991-656226, XP002250235 [A] 1-20 * abstract *
    [ ] - PATENT ABSTRACTS OF JAPAN, (19910910), vol. 015, no. 357, Database accession no. (C - 0866), & JP03141258 A 19910617 (KOWA) [ ] * abstract *
Examination   - SATO T ET AL, "Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199504), Database accession no. NLM7647953
    - SATO T ET AL, "Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome.", JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY APR 1995 LNKD- PUBMED:7647953, (199504), vol. 6, no. 4, ISSN 1045-3873, pages 279 - 282
    - BOUTJDIR M ET AL, "Early afterdepolarization formation in cardiac myocytes: analysis of phase plane patterns, action potential, and membrane currents.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199407), Database accession no. NLM7987531
    - BOUTJDIR M ET AL, "Early afterdepolarization formation in cardiac myocytes: analysis of phase plane patterns, action potential, and membrane currents.", JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY JUL 1994 LNKD- PUBMED:7987531, (199407), vol. 5, no. 7, ISSN 1045-3873, pages 609 - 620
    - KURITA T ET AL, "Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199301), Database accession no. NLM7681173
    - KURITA T ET AL, "Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.", PACING AND CLINICAL ELECTROPHYSIOLOGY : PACE JAN 1993 LNKD- PUBMED:7681173, (199301), vol. 16, no. 1 Pt 1, ISSN 0147-8389, pages 33 - 38
by applicantUS3845770
 US4326525
 US4567264
 US4902514
 US4992445
 US5001139
 US5023252
 US5616345
 WO0013687
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.